Frost & Sullivan Recognizes CyberMDX as the Leader in Medical Devices and Assets Security Technology Innovation

CyberMDX rated highest in Frost & Sulivan's Medical Device Security outlook for North America

September 16, 2020 9:00 AM EDT

NEW YORK, Sept. 16, 2020 /PRNewswire/ -- CyberMDX, a leading healthcare cybersecurity provider delivering visibility and threat prevention for medical devices and clinical networks, today announced that the company has received Frost & Sullivan's 2020 Technology Innovation Leadership Award as the leader in medical devices and assets security technology innovation in North America. The Technology Innovation Leadership Award recognizes companies that lead the development and successful introduction of high-tech solutions to customers' most pressing needs.

With increasing digitization of hospitals and a fast growing fleet of connected medical devices around the world, the quality and functionality of healthcare devices are at higher risk from data breaches than ever before. As such, cyber security is becoming an urgent requirement for all healthcare stakeholders to protect their critical medical devices and clinical assets on the Internet of Medical Things (IoMT).

According to the Frost & Sullivan report, "CyberMDX demonstrates thought leadership, technical excellence, and a unique customization ability to strengthen healthcare security through its platform. It also empowers the continuous discovery of medical devices and intelligent micro-segmentation policies and responses during cyberattacks."

CyberMDX developed its cyber intelligence platform to enable secure connectivity for medical devices and clinical assets. Through the platform's real-time threat monitoring and prevention capabilities, the company addresses the growing security challenges of healthcare delivery organizations in protecting networked medical devices in IoMT, strengthening hospital network security and medical device protection. CyberMDX utilizes AI to enable HDOs to accurately inventory their full fleets of medical devices, providing an unrivaled level of visibility for security teams while also providing real time monitoring and threat prevention capabilities.

"Frost & Sullivan's recognition of CyberMDX as the leader in medical device security innovation is exciting to see," said Amir Magner, CEO of CyberMDX. "The award is a testament to the hard work of our team and the high level of value we deliver to the medical community. Our mission at CyberMDX is to enable healthcare delivery organizations worldwide to provide quality care by securing and protecting the systems and devices they rely on every day to treat illnesses and save lives."

To read the full report please visit:

About CyberMDX

CyberMDX is an IOMT security leader dedicated to protecting the quality care of health delivery worldwide. CyberMDX provides cloud-based cybersecurity solutions that support the advancement of The Internet of Medical Things. The CyberMDX solution identifies endpoints and assesses vulnerabilities to detect, respond to, and prevent cyber incidents. Deployed worldwide, CyberMDX is designed to integrate with our customers' existing environments through its scalable, easy-to-deploy and agentless solution.

For more information visit or follow us on Twitter and LinkedIn.

Media Contact Lazer Cohen [email protected] +1-347-753-8256


Cision View original content:


Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

PRNewswire, Press Releases

Related Entities